Holen Sie sich die Stockscreener-App
0.3462
2.67%
-0.0095
Vorhandelsmarkt:
.34
-0.0062
-1.79%
Finanzdaten der Vyne Therapeutics Inc-Aktie (VYNE)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
65.84%
0.069
|
0.202 | 0.084 | 0.121 | 0.198 |
Operating Expenses
|
19.02%
7.611
|
9.399 | 12.85 | 13.21 | 10.59 |
| Benefits Costs and Expenses |
33.95%
5.816
|
8.805 | 12.09 | 12.28 | 9.593 |
| Costs And Expenses |
19.02%
7.611
|
9.399 | 12.85 | 13.21 | 10.59 |
| Operating Income/Loss |
17.99%
-7.542
|
-9.197 | -12.77 | -13.09 | -10.40 |
| Income/Loss From Continuing Operations Before Tax |
33.20%
-5.747
|
-8.603 | -12.01 | -12.16 | -9.395 |
| Income Tax Expense/Benefit |
-
|
- | 0.004 | - | - |
| Income/Loss From Continuing Operations After Tax |
33.20%
-5.747
|
-8.603 | -12.01 | -12.16 | -9.395 |
| Income/Loss From Discontinued Operations, Net Of Tax |
0.00%
-0.008
|
-0.008 | -0.008 | - | -0.011 |
|
Net Income/Loss
|
33.17%
-5.755
|
-8.611 | -12.02 | -12.16 | -9.406 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.20%
42.76
|
42.67 | -0.003 | 42.59 | 42.59 |
| Diluted Average Shares |
0.20%
42.76
|
42.67 | -0.003 | 42.59 | 42.59 |
| Basic Earnings Per Share |
35.00%
-0.13
|
-0.20 | -0.28 | -0.29 | -0.22 |
| Diluted Earnings Per Share |
35.00%
-0.13
|
-0.20 | -0.28 | -0.29 | -0.22 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):